Agilon Health (AGL)

• Market cap: $775M
• 1 day: -1.05%
• 5 days: -3.59%
• 1 month: -18.26%
• 3 months: -52.16%
• 6 months: -69.03%
• Year to date: -85.46%
• 1 year: -85.46%
• 5 years: -93.94%
• 10 years: -93.94%
• Sector: Healthcare
• Industry: Miscellaneous Health & Allied Services

About: Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Employees: 1,117

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

20% more call options, than puts

Call options by funds: $12.2M | Put options by funds: $10.2M

18% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 39

3% more funds holding

Funds holding: 203 [Q2] → 210 (+7) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

2% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 63

20.26% less ownership

Funds ownership: 124.65% [Q2] → 104.39% (-20.26%) [Q3]

50% less capital invested

Capital invested by funds: $3.35B [Q2] → $1.69B (-$1.67B) [Q3]

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $1.75 7% downside
• Avg. target: $2.58 37% upside
• High target: $4 113% upside

9 analyst ratings

• positive: 1 11%
• neutral: 5 56%
• negative: 3 33%

Macquarie Tao Qiu 27% 1-year accuracy 4 / 15 met price target	60% upside $3	Neutral Initiated	16 Dec 2024
Bernstein Lance Wilkes 33% 1-year accuracy 1 / 3 met price target	33% upside $2.50	Market Perform Initiated	11 Dec 2024
RBC Capital Sean Dodge 50% 1-year accuracy 21 / 42 met price target	60% upside $3	Outperform Reiterated	19 Nov 2024
Citigroup Daniel Grosslight 41% 1-year accuracy 7 / 17 met price target	7% downside $1.75	Sell Maintained	13 Nov 2024
Stifel Craig Jones 57% 1-year accuracy 4 / 7 met price target	6% upside $2	Hold Maintained	12 Nov 2024